By Leslie A. Pappas ( May 20, 2022, 5:02 PM EDT) -- A Delaware Chancery Court vice chancellor stopped short on Friday of penalizing clinical-stage biopharma company EpicentRx Inc. for what rival litigant Prothex Inc. called a "pattern" of missed deadlines in a case heading to trial next week, but he put the company on notice that it was "a close call."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.